Head of Investor Relations
Lycia Therapeutics
Lycia Therapeutics (Nasdaq: LYCA) is a clinical-stage biotechnology company using its proprietary lysosomal targeting chimera (LYTAC) platform to discover and…
yesterday
All Other Remote
L